Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Debt to Equity (2019 - 2020)

aTYR PHARMA (ATYR) has disclosed Debt to Equity for 2 consecutive years, with $0.1 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Debt to Equity fell 75.84% year-over-year to $0.1, compared with a TTM value of $0.1 through Sep 2020, down 75.84%, and an annual FY2019 reading of $0.42, changed N/A over the prior year.
  • Debt to Equity was $0.1 for Q3 2020 at aTYR PHARMA, down from $0.14 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.48 in Q1 2019 and bottomed at $0.1 in Q3 2020.